A Study of Local Envafolimab Injection Combined With Chemotherapy in Non-small Cell Lung Cancer
Status:
Recruiting
Trial end date:
2025-10-18
Target enrollment:
Participant gender:
Summary
The aim of this single-arm, exploratory clinical study is to evaluate the safety and efficacy
of local injection of envafolimab combined with chemotherapy in the first-line treatment of
non-small cell lung cancer (NSCLC) patients, and to observe the changes of immune cells in
the local immune microenvironment before and after immunotherapy, in order to find new
indicators for immunotherapy evaluation.